ENHI - ETF AI Analysis
Top Page
iShares Enhanced International Active ETF (ENHI)
ENHI, the iShares Enhanced International Active ETF, has a solid overall rating driven mainly by strong, diversified holdings like HSBC, Novartis, and AstraZeneca, which show healthy financial performance, positive earnings outlooks, and reasonable valuations. Additional support comes from companies such as ASML, Nestlé, Siemens, and Mitsubishi UFJ, though some holdings face valuation concerns, mixed technical signals, or cash flow challenges, and the fund’s concentration in large international financials and healthcare names is a key risk if those sectors weaken.
ENHI vs. SPDR S&P 500 ETF (SPY)
- AUM
- 21.21M
- Region
- Developed Markets
- Expense Ratio
- 0.27%
- Beta
- 0.81
- Issuer
- iShares
- Inception Date
- Mar 10, 2026
- Dividend Yield
- 1.17%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ENHI Summary
ENHI, the iShares Enhanced International Active ETF, invests in a wide mix of non-U.S. stocks across many countries and industries, aiming to beat the broader international market through active, data-driven stock picking rather than tracking a single index. Its holdings include well-known global companies like Nestlé, Shell, HSBC, Novartis, and ASML, giving investors diversified exposure to international markets and potential long-term growth. However, because it is actively managed and focused on foreign stocks, its value can move differently from simple index funds and can go up and down with global market swings and currency changes.
How much will it cost me?
This ETF has an expense ratio of 0.27%, which means you’ll pay about $2.70 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because ENHI is actively managed, using data-driven stock selection instead of simply tracking a market index.
What would affect this ETF?
This ETF focuses on developed markets outside North America and holds many large financial, industrial, health care, and technology companies, so it could benefit if global growth stays solid, interest rates stabilize or fall, and innovation and consumer demand remain strong in Europe and Asia. On the other hand, it could be hurt by economic slowdowns overseas, banking or regulatory issues affecting its big financial holdings, higher interest rates that pressure stocks broadly, or if its active, data-driven strategy fails to pick the right companies compared with simple index funds.
ENHI Top 10 Holdings
ENHI leans heavily into developed markets outside North America, with a clear tilt toward European heavyweights. ASML is a key swing factor: its longer-term rise has helped the fund, but recent weakness means it’s no longer the engine it was earlier in the year. Health care names like Roche and Novartis are quietly pulling their weight, offering steady, rising performance that smooths volatility. SAP has turned into a bright spot with strong recent momentum, while financials such as HSBC and Mitsubishi UFJ show more mixed, stop‑and‑go progress, keeping overall returns in check.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 2.86% | $608.54K | EUR 529.05B | 45.71% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 GB:SHEL | Shell (UK) | 1.64% | $349.73K | GBP 219.31B | 33.74% | 73Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 GB:HSBA | HSBC Holdings | 1.44% | $306.89K | GBP 215.55B | 22.62% | 80Outperform |
 CH:NOVN | Novartis AG | 1.41% | $300.50K | CHF 240.72B | 32.30% | 80Outperform |
 CH:NESN | Nestlé SA | 1.29% | $275.06K | CHF 217.12B | 8.87% | 71Outperform |
 DE:SIE | Siemens | 1.26% | $268.50K | EUR 205.62B | 12.88% | 74Outperform |
 JP:8306 | Mitsubishi UFJ Financial Group | 1.24% | $263.57K | JPY 38.08T | 44.08% | 76Outperform |
 DE:SAP | SAP SE | 1.19% | $252.43K | EUR 241.28B | -5.20% | 66Neutral |
ENHI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ENHI, the sentiment is Positive. The current price of 27.05 is above the 20-day moving average (MA) of 26.55, above the 50-day MA of 26.92, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.05 indicates Negative momentum. The RSI at 57.77 is Neutral, neither overbought nor oversold. The STOCH value of 58.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ENHI.
ENHI Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ENHI | $27.05 | $29.00(7.19% Upside) | $21.21M | 0.27% | 66Neutral |
 QUIZ | $28.55 | $33.74(18.17% Upside) | $95.50M | 0.55% | 65Neutral |
 JIDE | $51.68 | $58.62(13.43% Upside) | $80.42M | 0.55% | 68Neutral |
 AIVI | $59.27 | $75.12(26.74% Upside) | $57.78M | 0.58% | 64Neutral |
 TACN | $28.94 | $33.38(15.35% Upside) | $24.00M | 0.00% | 66Neutral |
 IVSI | $29.75 | $33.69(13.24% Upside) | $9.50M | 0.65% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ENHI | iShares Enhanced International Active ETF | 27.05 | 2.81 | 11.60% | |
| QUIZ | Zacks Quality International ETF | 28.55 | 2.98 | 11.64% | |
| JIDE | JPMorgan International Dynamic ETF | 51.67 | 2.36 | 4.78% | |
| AIVI | WisdomTree International AI Enhanced Value Fund | 59.27 | 12.28 | 26.13% | |
| TACN | T. Rowe Price Active Core International Equity ETF | 28.94 | 3.71 | 14.68% | |
| IVSI | Applied Finance IVS International Large ETF | 29.75 | 4.18 | 16.34% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.